View Cart (0 items)

Pharmaceutical

US wholesale sector consolidation hits Indian drug makers

The U.S. pharmaceutical sector is going through a period of consolidation and this has already has a noticeable effect on Indian drug makers.
Read More

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

Lupin recalls 9,000 bottles of antibiotic drug

Two lots of Suprax, an antibiotic drug used to treat bacterial infections, are being withdrawn from the U.S. market because the product does not meet federal standards for impurities.
Read More

US, EU generic drug makers call for regulatory cooperation

Generic pharmaceuticals manufacturers from Europe and the United States have urged regulators on both sides of the Atlantic to adopt a strategy of "regulatory convergence."
Read More

Scientists find benefits of Tamiflu overestimated

A new study raises concerns that the effect of the vastly popular influenza treatment drug may have been overestimated.
Read More

Teva's application for patent extension on Copaxone rejected

The U.S. Patent and Trademark Office has rejected the request from Israeli pharma giant Teva Pharmaceuticals to have its patent protection on Copaxone extended until September 2015.
Read More

US demand for pharma excipients to rise 4.3% per year through 2018

Excipients in oral formulations, such as tablets and capsules, will be well positioned for strong market performance.
Read More

FDA reviewer slams study that questions generic drug quality

A senior official with the U.S. FDA has slammed research that suggests many heart drugs produced outside the U.S. contain impurities.
Read More

Horizon Pharma buys Irish drug maker Vidara

Illinois-based Horizon Pharma Inc. announced last week it was taking over Irish Vidara Therapeutics International Ltd. in a reverse merger, moving its headquarters to Dublin.
Read More

Pfizer seeks to ban sales of generic Viagra in US

U.S. pharmaceutical corporation Pfizer has filed a lawsuit against Indian drug maker Torrent Pharmaceuticals Ltd. in an effort to prevent sales of a generic version of Viagra.
Read More